Fulcrum Therapeutics, Inc. FULC
3.77 USD +0.03 (+0.80%)
At closeNov 4, 2026, 4:01 PM EST
3.77 0.00 0.00%
After hours · Nov 4, 4:01 PM ET
3.73 Day range 3.78
2.83 52-week range 15.74
- YTD
- -66.67%
- 1 year
- -54.96%
Held by funds
67 US ETFs and mutual funds hold FULC · largest positions
Ownership
Held by insiders 1.62%
Held by institutions 89.70%
Float held by institutions 91.17%
Institutions 165
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 18.96% | 10,229,099 | 47.87M | Sep 29, 2024 |
| Blackrock Inc. | 10.58% | 5,706,527 | 26.71M | Sep 29, 2024 |
| TCG Crossover Management, LLC | 9.73% | 5,250,000 | 24.57M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 8.86% | 4,777,912 | 22.36M | Sep 29, 2024 |
| Vanguard Group Inc | 6.07% | 3,274,592 | 15.33M | Sep 29, 2024 |
| TRV GP IV, LLC | 4.34% | 2,343,154 | 10.97M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.43% | 1,852,255 | 8.67M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 3.01% | 1,626,094 | 7.61M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.45% | 782,473 | 3.66M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 1.18% | 636,809 | 2.98M | Aug 30, 2024 |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Pharmaceuticals ETF | 0.92% | 493,858 | 2.31M | Sep 29, 2024 |
| iShares Biotechnology ETF | 0.75% | 407,174 | 1.91M | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GOULD ROBERT J. | Chief Executive Officer | Sale | Jan 12, 2023 | 499,864 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 19, 2023 | 0 |
| SAPIR ALEX | Chief Executive Officer | Conversion of Exercise of derivative security | Jul 2, 2024 | 193,360 |
| TOURANGEAU GREG | Officer | Sale | May 6, 2024 | 11,571 |